Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Surveillance of Financial Conflict Of Interest Needs To Increase - Henney

Executive Summary

Increased surveillance of financial conflict of interest is needed to guard against even a perception of bias by the public, FDA Commissioner Henney indicated during HHS' meeting on human subject protection and financial conflict of interest Aug. 15 at NIH.

You may also be interested in...



Human Subject Research Guidance Urges Individual Financial Conflict Criteria

Institutions engaged in federally conducted or supported human subjects research should establish their own criteria on what constitutes an institutional financial conflict of interest, an HHS draft guidance states

Human Subject Research Guidance Urges Individual Financial Conflict Criteria

Institutions engaged in federally conducted or supported human subjects research should establish their own criteria on what constitutes an institutional financial conflict of interest, an HHS draft guidance states

Human Subject Protection Systems At Five Universities Under Review By GAO

The General Accounting Office is visiting five of the top 10 federally funded public and private research universities to review their systems for protecting human research subjects and handling conflict of interest issues.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel